NVO
Novo Nordisk ADR
3월 13일 4:00 PM ET (한국 3/14 05:00)
$37.96
-0.06 ▼ -0.16%
🌙 3월 13일 8:00 PM ET (한국 3/14 09:00)
$37.95
-0.01 ▼ -0.03%
| Index | - | P/E | 10.95 | EPS (ttm) | 3.47 | Insider Own | 0.01% | Shs Outstand | 3.37B | Perf Week | -1.61% |
| Market Cap | 127.89B | Forward P/E | 11.28 | EPS next Y | 2.29% | Insider Trans | - | Shs Float | 3.37B | Perf Month | -22.12% |
| Enterprise Value | 144.24B | PEG | 80.6 | EPS next Q | 0.92 | Inst Own | 9.44% | Short Float | 0.84% | Perf Quarter | -22.61% |
| Income | 15.45B | P/S | 2.73 | EPS this Y | -9.6% | Inst Trans | -0.4% | Short Ratio | 1.16 | Perf Half Y | -30.09% |
| Sales | 46.77B | P/B | 5.53 | EPS next 5Y | 0.14% | ROA | 20.59% | Short Interest | 28.26M | Perf YTD | -25.39% |
| Book/sh | 6.87 | P/C | 30.17 | EPS past 3/5Y | 26.28% 20.36% | ROE | 61.25% | 52W High | -54.03% ($82.57) | Perf Year | -49.98% |
| Cash/sh | 1.26 | P/FCF | 14.29 | Sales past 3/5Y | 23.19% 19.21% | ROIC | 31.38% | 52W Low | 5.89% ($35.85) | Perf 3Y | -45.98% |
| Dividend Est. | $1.66 (4.37%) | EV/EBITDA | 6.38 | EPS Y/Y TTM | 5.57% | Gross Margin | 80.9% | Volatility(W/M) | 2.71% 2.43% | Perf 5Y | 6.91% |
| Dividend TTM | 1.73 | EV/Sales | 3.08 | Sales Y/Y TTM | 11.11% | Oper. Margin | 41.17% | ATR (14) | 1.66 | Perf 10Y | 33.15% |
| Dividend Ex-Date | 2026/3/30 | Quick Ratio | 0.57 | EPS Q/Q | 3.95% | Profit Margin | 33.03% | RSI (14) | 32.79 | Recom | 2.5 |
| Dividend Gr. 3/5Y | 28.28% 20.66% | Current Ratio | 0.8 | Sales Q/Q | 0.66% | SMA20 | -7.34% ($40.97) | Beta | 0.74 | Target Price | $49.14 |
| Payout | 38.07% | Debt/Eq | 0.67 | Earnings | 2000000 | SMA50 | -24.04% ($49.97) | Rel Volume | 0.48 | Prev Close | $38.02 |
| Employees | 68794 | LT Debt/Eq | 0.61 | EPS/Sales Surpr. | 3.4% 3.1% | SMA200 | -31.89% ($55.73) | Avg Volume(3M) | 24.31M | Price | $37.96 |
| IPO | 1981/4/30 | Option/Short | Yes/Yes | Trades | 54190 | Volume | 11,607,471 | Change | -0.16% |
뉴스 로딩 중...